News | April 10, 2009

SCAI Hosts Scientific Sessions May 6-9 in Las Vegas

April 10, 2009 - The Society for Cardiovascular Angiography and Interventions (SCAI) will host its annual scientific sessions May 6-9 in Las Vegas, NV.

This year’s meeting will highlight the latest research and hottest topics in interventional cardiology. Highlights will include late-breaking clinical trials, including the AMADEUS trial on percutaneous mitral valve repair and new results from The Clopidogrel Medco Outcomes Study on the effects of clopidogrel and individual PPIs. Practice-changing trials and abstracts sessions will review how the major trials of the past 12 months impact patient care, including SYNTAX, FREEDOM and others.

Keynote addresses include simplifying approval of children’s devices by Charles E. Mullins, M.D., FSCAI, what the latest studies say about utilization of angioplasty by Paul Teirstein, M.D., and the qualities that comprise professionalism in medicine by Christopher J. White, M.D., FSCAI.

The event also includes emerging technology and therapy sessions on future stent technology, percutaneous valve technology and antiplatelet drugs. Live cases will be presented on a variety of topics, including left main and bifurcation, structural heart disease, and others.

Other key themes of research to be presented include structural heart disease, radial versus femoral PCI, inpatient versus outpatient PCI, disparities between men and women, and treatment of octogenarians.

For more information: www.scai.org

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init